Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 36 pages - $1,000
May 2011 - 22 pages - $500
Nov 2010 - 40 pages - $500
Oct 2009 - 17 pages - $500
Dec 2010 - 35 pages - $1,000
Nov 2011 - 7 pages - $3,835
Jun 2006 - 1458 pages - $2,495
Oct 2011 - 150 pages - $3,500
Nov 2010 - 40 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us